Abstract
Dust mites are an important cause of allergic diseases worldwide. The traces of Dermatophagoides farinae and Dermatophagoides pteronyssinus can be found all over the world, while Blomia tropicalis are more common allergenic mites in tropical areas. A variety of allergenic components in dust mites have been found, apart from the different positive rates of IgE reactions in dust mite allergic patients, their biological characteristics, effects on the innate immune system, and especially their distribution characteristics in patients are different. Studying the relationship between dust mite allergens and clinical significance will help for diagnosis of patients and formulation of corresponding Allergen Specific Immunotherapy.
Similar content being viewed by others
References
Voorhorst R, Spieksma-Boezeman M, Spieksma F (1964) Is a mite (Dermatophagoides Sp.) the producer of the house-dust allergen? Allergy Asthma 10:329–334
Tovey ER, Chapman MD, Platts-Mills TA (1981) Mite faeces are a major source of house dust allergens. Nature 289(5798):592–593
Fernández-Caldas E (1997) Mite species of allergologic importance in Europe. Allergy 52(4):383–387
Liu XY, Yang KY, Wang MQ, Kwok JS, Zeng X, Yang Z, Xiao XJ, Lau CP, Li Y, Huang ZM et al (2018) High-quality assembly of Dermatophagoides pteronyssinus genome and transcriptome reveals a wide range of novel allergens. J Allergy Clin Immunol 141(6):2268–2271.e2268
Curin M, Khaitov M, Karaulov A, Namazova-Baranova L, Campana R, Garib V, Valenta R (2018) Next-generation of allergen-specific immunotherapies: molecular approaches. Curr Allergy Asthma Rep 18(7):39
Yang L, Zhu R (2017) Immunotherapy of house dust mite allergy. Hum Vaccin Immunother 13(10):2390–2396
Mrkic I, Minic R, Popovic D, Zivkovic I, Gavrovic-Jankulovic M (2018) Newly designed hemagglutinin-Der p 2 chimera is a potential candidate for allergen specific immunotherapy. Life Sci 213:158–165
Chen KW, Blatt K, Thomas WR, Swoboda I, Valent P, Valenta R, Vrtala S (2012) Hypoallergenic Der p 1/Der p 2 combination vaccines for immunotherapy of house dust mite allergy. J Allergy Clin Immunol 130(2):435–443.e434
Hesse L, van Ieperen N, Habraken C, Petersen AH, Korn S, Smilda T, Goedewaagen B, Ruiters MH, van der Graaf AC, Nawijn MC (2018) Subcutaneous immunotherapy with purified Der p1 and 2 suppresses type 2 immunity in a murine asthma model. Allergy 73(4):862–874
Green W, Woolcock AJ, Dowse G (1982) House dust mites in blankets and houses in the highlands of Papua New Guinea. P N G Med J 25(4):219–222
Sander I, Zahradnik E, Kraus G, Mayer S, Neumann HD, Fleischer C, Brüning T, Raulf-Heimsoth M (2012) Domestic mite antigens in floor and airborne dust at workplaces in comparison to living areas: a new immunoassay to assess personal airborne allergen exposure. PLoS ONE 7(12):e52981
Tovey ER, Mahmic A, McDonald LG (1995) Clothing--an important source of mite allergen exposure. J Allergy Clin Immunol 96(6 Pt 1):999–1001
Murray AB, Ferguson AC, Morrison BJ (1985) Sensitization to house dust mites in different climatic areas. J Allergy Clin Immunol 76(1):108–112
Kaw Yan Chua NC, Kuo I-C, Lee BW, Yi FC, Huang C-H, Liew LN (2007) The Blomia tropicalis allergens. Protein Pept Lett 14(4):325–333. https://doi.org/10.2174/092986607780363862
Batard T, Baron-Bodo V, Martelet A, Le Mignon M, Lemoine P, Jain K, Mariano S, Horiot S, Chabre H, Harwanegg C et al (2016) Patterns of IgE sensitization in house dust mite-allergic patients: implications for allergen immunotherapy. Allergy 71(2):220–229
Carnes J, Iraola V, Cho SH, Esch RE (2017) Mite allergen extracts and clinical practice. Ann Allergy Asthma Immunol 118(3):249–256
Tovey ER, Chapman MD, Wells CW, Platts-Mills TA (1981) The distribution of dust mite allergen in the houses of patients with asthma. Am Rev Respir Dis 124(5):630–635
Schatz M, Rosenwasser L (2014) The allergic asthma phenotype. J Allergy Clin Immunol Pract 2(6):645–648; quiz 649
Jacquet A, Campisi V, Szpakowska M, Dumez ME, Galleni M, Chevigné A (2017) Profiling the extended cleavage specificity of the house dust mite protease allergens Der p 1, Der p 3 and Der p 6 for the prediction of new cell surface protein substrates. Int J Mol Sci 18(7)
Huang FL, Liao EC, Yu SJ (2018) House dust mite allergy: its innate immune response and immunotherapy. Immunobiology 223(3):300–302
Wan H, Winton HL, Soeller C, Tovey ER, Gruenert DC, Thompson PJ, Stewart GA, Taylor GW, Garrod DR, Cannell MB et al (1999) Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin Invest 104(1):123–133
Asokananthan N, Graham PT, Stewart DJ, Bakker AJ, Eidne KA, Thompson PJ, Stewart GA (2002) House dust mite allergens induce proinflammatory cytokines from respiratory epithelial cells: the cysteine protease allergen, Der p 1, activates protease-activated receptor (PAR)-2 and inactivates PAR-1. J Immunol 169(8):4572–4578
Yin SC, Liao EC, Chiu CL, Chang CY, Tsai JJ (2015) Der p2 internalization by epithelium synergistically augments toll-like receptor-mediated Proinflammatory Signaling. Allergy Asthma Immunol Res 7(4):393–403
Reginald K, Chew FT (2019) The major allergen Der p 2 is a cholesterol binding protein. Sci Rep 9(1):1556
Herman J, Thelen N, Smargiasso N, Mailleux AC, Luxen A, Cloes M, De Pauw E, Chevigné A, Galleni M, Dumez ME (2014) Der p 1 is the primary activator of Der p 3, Der p 6 and Der p 9 the proteolytic allergens produced by the house dust mite Dermatophagoides pteronyssinus. Biochim Biophys Acta 1840(3):1117–1124
Mueller GA, Edwards LL, Aloor JJ, Fessler MB, Glesner J, Pomés A, Chapman MD, London RE, Pedersen LC (2010) The structure of the dust mite allergen Der p 7 reveals similarities to innate immune proteins. J Allergy Clin Immunol 125(4):909–917.e904
Arlian LG, Morgan MS, Vyszenski-Moher DL, Sharra D (2009) Cross-reactivity between storage and dust mites and between mites and shrimp. Exp Appl Acarol 47(2):159–172
Banerjee S, Resch Y, Chen KW, Swoboda I, Focke-Tejkl M, Blatt K, Novak N, Wickman M, van Hage M, Ferrara R et al (2015) Der p 11 is a major allergen for house dust mite-allergic patients suffering from atopic dermatitis. J Invest Dermatol 135(1):102–109
Fernández-Caldas E (2013) On mite allergy in dogs and humans. Int Arch Allergy Immunol 160(4):329–330
Weghofer M, Grote M, Resch Y, Casset A, Kneidinger M, Kopec J, Thomas WR, Fernandez-Caldas E, Kabesch M, Ferrara R et al (2013) Identification of Der p 23, a peritrophin-like protein, as a new major Dermatophagoides pteronyssinus allergen associated with the peritrophic matrix of mite fecal pellets. J Immunol 190(7):3059–3067
Matos Semedo F, Dorofeeva Y, Pires AP, Tomaz E, Taborda Barata L, Inacio F, Valenta R (2019) Der p 23: clinical relevance of molecular Monosensitization in house dust mite allergy. J Investig Allergol Clin Immunol 29(4):314–316
Múnera M, Martínez D, Labrada A, Caraballo L, Puerta L (2019) Identification of B cell epitopes of Blo t 13 allergen and cross-reactivity with human adipocytes and heart fatty acid binding proteins. Int J Mol Sci 20(24)
Chua KY, Cheong N, Kuo IC, Lee BW, Yi FC, Huang CH, Liew LN (2007) The Blomia tropicalis allergens. Protein Pept Lett 14(4):325–333
Chapman MD, Platts-Mills TA (1980) Purification and characterization of the major allergen from Dermatophagoides pteronyssinus-antigen P1. J Immunol 125(2):587–592
Chua KY, Stewart GA, Thomas WR, Simpson RJ, Dilworth RJ, Plozza TM, Turner KJ (1988) Sequence analysis of cDNA coding for a major house dust mite allergen, Der p 1. Homology with cysteine proteases. J Exp Med 167(1):175–182
By Lucy Gough OS, Sewell HF, Shakib F (1999) The cysteine protease activity of the major dust mite allergen Der p 1. J Exp Med
Luczynska C, Sterne J, Bond J, Azima H, Burney P (1998) Indoor factors associated with concentrations of house dust mite allergen, Der p 1, in a random sample of houses in Norwich, UK. Clin Exp Allergy 28(10):1201–1209
Marks GB, Tovey ER, Toelle BG, Wachinger S, Peat JK, Woolcock AJ (1995) Mite allergen (Der p 1) concentration in houses and its relation to the presence and severity of asthma in a population of Sydney schoolchildren. J Allergy Clin Immunol 96(4):441–448
Miranda DO, Silva DA, Fernandes JF, Queiros MG, Chiba HF, Ynoue LH, Resende RO, Pena JD, Sung SS, Segundo GR et al (2011) Serum and salivary IgE, IgA, and IgG4 antibodies to Dermatophagoides pteronyssinus and its major allergens, Der p1 and Der p2, in allergic and nonallergic children. Clin Dev Immunol 2011:302739
Mueller GA, Randall TA, Glesner J, Pedersen LC, Perera L, Edwards LL, DeRose EF, Chapman MD, London RE, Pomes A (2016) Serological, genomic and structural analyses of the major mite allergen Der p 23. Clin Exp Allergy 46(2):365–376
Jalaludin B, Xuan W, Mahmic A, Peat J, Tovey E, Leeder S (1998) Association between Der p 1 concentration and peak expiratory flow rate in children with wheeze: a longitudinal analysis. J Allergy Clin Immunol 102(3):382–386
De Lucca S, Sporik R, O'Meara TJ, Tovey ER (1999) Mite allergen (Der p 1) is not only carried on mite feces. J Allergy Clin Immunol 103(1 Pt 1):174–175
Tulic MK, Vivinus-Nébot M, Rekima A, Rabelo Medeiros S, Bonnart C, Shi H, Walker A, Dainese R, Boyer J, Vergnolle N et al (2016) Presence of commensal house dust mite allergen in human gastrointestinal tract: a potential contributor to intestinal barrier dysfunction. Gut 65(5):757–766
Ghaemmaghami AM, Shakib F (2002) Human T cells that have been conditioned by the proteolytic activity of the major dust mite allergen Der p 1 trigger enhanced immunoglobulin E synthesis by B cells. Clin Exp Allergy 32(5):728–732
Schulz O, Sewell HF, Shakib F (1998) Proteolytic cleavage of CD25, the alpha subunit of the human T cell interleukin 2 receptor, by Der p 1, a major mite allergen with cysteine protease activity. J Exp Med 187(2):271–275
Hewitt CR, Brown AP, Hart BJ, Pritchard DI (1995) A major house dust mite allergen disrupts the immunoglobulin E network by selectively cleaving CD23: innate protection by antiproteases. J Exp Med 182(5):1537–1544
Chua KY, Doyle CR, Simpson RJ, Turner KJ, Stewart GA, Thomas WR (1990) Isolation of cDNA coding for the major mite allergen Der p II by IgE plaque immunoassay. Int Arch Allergy Appl Immunol 91(2):118–123
Park GM, Lee SM, Lee IY, Ree HI, Kim KS, Hong CS, Yong TS (2000) Localization of a major allergen, Der p 2, in the gut and faecal pellets of Dermatophagoides pteronyssinus. Clin Exp Allergy 30(9):1293–1297
Heymann PW, Chapman MD, Aalberse RC, Fox JW, Platts-Mills TA (1989) Antigenic and structural analysis of group II allergens (Der f II and Der p II) from house dust mites (Dermatophagoides spp). J Allergy Clin Immunol 83(6):1055–1067
Gore RB, Hadi EA, Craven M, Smillie FI, O'Meara TJ, Tovey ER, Woodcock A, Custovic A (2002) Personal exposure to house dust mite allergen in bed: nasal air sampling and reservoir allergen levels. Clin Exp Allergy 32(6):856–859
Trombone AP, Tobias KR, Ferriani VP, Schuurman J, Aalberse RC, Smith AM, Chapman MD, Arruda LK (2002) Use of a chimeric ELISA to investigate immunoglobulin E antibody responses to Der p 1 and Der p 2 in mite-allergic patients with asthma, wheezing and/or rhinitis. Clin Exp Allergy 32(9):1323–1328
Hammad H, Chieppa M, Perros F, Willart MA, Germain RN, Lambrecht BN (2009) House dust mite allergen induces asthma via toll-like receptor 4 triggering of airway structural cells. Nat Med 15(4):410–416
Liao EC, Hsieh CW, Chang CY, Yu SJ, Sheu ML, Wu SM, Tsai JJ (2015) Enhanced allergic inflammation of Der p 2 affected by polymorphisms of MD-2 promoter. Allergy, Asthma Immunol Res 7(5):497–506
Hales BJ, Hazell LA, Smith W, Thomas WR (2002) Genetic variation of Der p 2 allergens: effects on T cell responses and immunoglobulin E binding. Clin Exp Allergy 32(10):1461–1467
Zheng YW, Li J, Lai XX, Zhao DY, Liu XF, Lin XP, Gjesing B, Palazzo P, Mari A, Zhong NS et al (2011) Allergen micro-array detection of specific IgE-reactivity in Chinese allergy patients. Chin Med J 124(24):4350–4354
Trompette A, Divanovic S, Visintin A, Blanchard C, Hegde RS, Madan R, Thorne PS, Wills-Karp M, Gioannini TL, Weiss JP et al (2009) Allergenicity resulting from functional mimicry of a toll-like receptor complex protein. Nature 457(7229):585–588
Posa D, Perna S, Resch Y, Lupinek C, Panetta V, Hofmaier S, Rohrbach A, Hatzler L, Grabenhenrich L, Tsilochristou O et al (2017) Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens during the first 2 decades of life. J Allergy Clin Immunol 139(2):541–549.e548
Celi G, Brusca I, Scala E, Villalta D, Pastorello E, Farioli L, Cortellini G, Deleonardi G, Galati P, Losappio L et al (2019) House dust mite allergy in Italy-diagnostic and clinical relevance of Der p 23 (and of minor allergens): a real-life, multicenter study. Allergy 74(9):1787–1789
Jimenez-Feijoo R, Pascal M, Moya R, Riggioni C, Dominguez O, Lozano J, Alvaro-Lozano M, Piquert M, Machinena A, Folque M et al (2019) Molecular diagnosis in house dust mite allergic patients suggests clinical relevance of Der p 23 in asthmatic children. J Investig Allergol Clin Immunol
Huang HW, Lue KH, Wong RH, Sun HL, Sheu JN, Lu KH (2006) Distribution of allergens in children with different atopic disorders in Central Taiwan. Acta Paediatr Taiwan 47(3):127–134
Trakultivakorn M, Nuglor T (2002) Sensitization to Dermatophagoides pteronyssinus and Blomia tropicalis extracts and recombinant mite allergens in atopic Thai patients. Asian Pac J Allergy Immunol 20(4):217–221
Pires MC, Calux MJ, Mori JC, Montealegre F (2002) Reactivity of anti-Blomia tropicalis IgG and IgE in patients with atopic dermatitis. Clin Exp Dermatol 27(4):309–313
Kuo IC, Cheong N, Trakultivakorn M, Lee BW, Chua KY (2003) An extensive study of human IgE cross-reactivity of Blo t 5 and Der p 5. J Allergy Clin Immunol 111(3):603–609
Mercado D (2007) IgE antibody responses to recombinant allergens of Blomia tropicalis and Dermatophagoides pteronyssinus in a tropical environment. Allergy Clin Immunol Int J World Allergy Organ 19(6):233
Sidenius KE, Hallas TE, Poulsen LK, Mosbech H (2001) Allergen cross-reactivity between house-dust mites and other invertebrates. Allergy 56(8):723–733
Weghofer M, Thomas WR, Kronqvist M, Mari A, Purohit A, Pauli G, Horak F, Grönlund H, van Hage M, Valenta R et al (2008) Variability of IgE reactivity profiles among European mite allergic patients. Eur J Clin Investig 38(12):959–965
Asturias JA, Arilla MC, Gómez-Bayón N, Martínez A, Martínez J, Palacios R (1998) Sequencing and high level expression in Escherichia coli of the tropomyosin allergen (Der p 10) from Dermatophagoides pteronyssinus. Biochim Biophys Acta 1397(1):27–30
Pittner G, Vrtala S, Thomas WR, Weghofer M, Kundi M, Horak F, Kraft D, Valenta R (2004) Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens. Clin Exp Allergy 34(4):597–603
Resch Y, Weghofer M, Seiberler S, Horak F, Scheiblhofer S, Linhart B, Swoboda I, Thomas WR, Thalhamer J, Valenta R et al (2011) Molecular characterization of Der p 10: a diagnostic marker for broad sensitization in house dust mite allergy. Clin Exp Allergy 41(10):1468–1477
Zimmer J, Bonertz A, Vieths S (2017) Quality requirements for allergen extracts and allergoids for allergen immunotherapy. Allergol Immunopathol 45:4–11
Huang HJ, Curin M, Banerjee S, Chen KW, Garmatiuk T, Resch-Marat Y, Carvalho-Queiroz C, Blatt K, Gafvelin G, Grönlund H et al (2019) A hypoallergenic peptide mix containing T cell epitopes of the clinically relevant house dust mite allergens. Allergy 74(12):2461–2478
Reginald K, Chew FT (2018) Conformational IgE epitope mapping of Der p 2 and the evaluations of two candidate Hypoallergens for immunotherapy. Sci Rep 8(1):3391
Olaguíbel JM, Tabar AI, García BE, Martín S, Rico P (1999) Long-term immunotherapy with an optimal maintenance dose of a standardized Dermatophagoides pteronyssinus extract in asthmatic patients. J Investig Allergol Clin Immunol 9(2):110–116
Acknowledgements
The author wish to thank other members of the same research group for their suggestions.
Funding
Professor Zhigang Liu was funded by National Natural Science Foundation of China (Nos. 31729002, U1801286 and 81971514) and Key Projects of Guangdong (China) Science and Technology Plan (No. 2017b0226006).
Author information
Authors and Affiliations
Contributions
HC wrote the manuscript and contributed to the final revision of the manuscript. ZL involved in the critical revision and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Hui Cao declares that he has no conflict of interest. Zhigang Liu declares that he has no conflict of interest.
Ethical approval
This review does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Cao, H., Liu, Z. Clinical significance of dust mite allergens. Mol Biol Rep 47, 6239–6246 (2020). https://doi.org/10.1007/s11033-020-05613-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-020-05613-1